Provided by Tiger Trade Technology Pte. Ltd.

Ultragenyx Pharmaceutical

14.84
+0.34002.34%
Volume:5.41M
Turnover:78.80M
Market Cap:1.46B
PE:-2.55
High:15.04
Open:14.68
Low:14.07
Close:14.50
52wk High:39.89
52wk Low:12.73
Shares:98.32M
Float Shares:80.72M
Volume Ratio:1.55
T/O Rate:6.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8279
EPS(LYR):-5.8316
ROE:-608.47%
ROA:-24.22%
PB:-5.01
PE(LYR):-2.54

Loading ...

Ultragenyx Pharmaceutical (RARE) Receives a Buy from Wells Fargo

TIPRANKS
·
May 06

Barclays Keeps Their Buy Rating on Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
May 06

Ultragenyx Pharmaceutical Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 06

REFILE-Ultragenyx Q1 revenue drop steeper than estimated; backs FY view

Reuters
·
May 06

Ultragenyx Pharmaceutical Q1 EPS $(1.84) Misses $(1.51) Estimate, Sales $136.000M Miss $158.777M Estimate

Benzinga Earnings
·
May 06

BRIEF-Ultragenyx Q1 EPS USD -1.84

Reuters
·
May 06

Ultragenyx Q1 net loss widens to $185 million; revenue slips to $136 million

Reuters
·
May 06

Ultragenyx Pharmaceutical Inc: Reaffirms 2026 Financial Guidance

THOMSON REUTERS
·
May 06

Ultragenyx Pharmaceutical Inc: Remain on Path to Profitability in 2027

THOMSON REUTERS
·
May 06

Ultragenyx CFO Howard Horn disposes 4,683 shares worth $116,607.70

Reuters
·
May 05

Press Release: WisdomTree Announces First Quarter 2026 Results

Dow Jones
·
May 01

Northwest Bio appoints Annalisa Jenkins as strategic adviser

Reuters
·
May 01

Ultragenyx Pharma Is Maintained at Overweight by Barclays

Dow Jones
·
Apr 29

Ultragenyx to Host Conference Call for First Quarter 2026 Financial Results and Corporate Update

GlobeNewswire
·
Apr 29

Ultragenyx price target lowered to $43 from $44 at Barclays

TIPRANKS
·
Apr 29

Analysts Offer Insights on Healthcare Companies: CareDx (CDNA) and Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Apr 29

Ultragenyx grants 36,447 inducement RSUs to 12 new hires

Reuters
·
Apr 25

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Apr 25

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Medpace Holdings (MEDP) and Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Apr 24

Wedbush Lifts Price Target on Ultragenyx Pharmaceutical to $27 From $25, Keeps Neutral Rating

MT Newswires Live
·
Apr 21